Rajbhog Sweets Yellow Jalebi
Reason Product label lists "butter" on the but does not include the common name for the allergen "milk"
Rajbhog Sweets Orange Jalebi recall
Recalled by Rajbhog Distributors, Inc · Dallas, TX, United States
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Product label lists "butter" on the but does not include the common name for the allergen "milk"
Undeclared allergen: Milk
For someone with a food allergy the label is the only protection. An undeclared allergen can trigger a severe reaction even in a trace amount, which is why most of these recalls are Class I. All undeclared allergens recalls.
What was recalled
Rajbhog Sweets Orange Jalebi Net Weight: 10 oz. UPC 3542647018 packaged in a plastic container and in bulk sold by weight
Quantity: 581 units and 317 pounds
Lot codes, dates and UPCs
A recall covers only these codes. Compare them with the lot number, best-by date or UPC printed on your package.
Best by date: 04/05/23
Where it was sold
Texas
FDA's distribution note: Dallas, Plano, Frisco, Irving, Sugarland and Austin Texas areas.
Check the codes, then return or discard. Class II means eating it may cause temporary or reversible health problems. If your package matches the recalled codes, do not eat it - return it to the store or throw it away. The risk from an undeclared allergen is to people allergic to milk; for anyone else the product is generally not a safety concern. FDA lists this recall as terminated: the company has finished removing the product, so it should no longer be on shelves - but it can still be in a freezer or pantry.
- Recalling firm
- Rajbhog Distributors, Inc
- Initiated by
- Voluntary: Firm initiated
- Recall initiated
- Feb 10, 2023
- In FDA report of
- May 3, 2023
- Terminated
- Apr 18, 2024
- FDA recall number
- F-0762-2023 · event 91779
- Official record
- FDA enforcement report search
Also recalled with it (1 more product)
FDA files each product of one recall action separately; these share the same FDA event.